Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Melcher

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Cancer Immunology Research|October 18, 2017
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor RecurrenceTim Kottke, Laura Evgin, Kevin G Shim, et al.
Frontiers in Oncology|January 18, 2024
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignanciesPablo Nenclares, Adrian Larkeryd, Floriana Manodoro, et al.
Cancer Immunology Research|September 14, 2018
Antibody-Neutralized Reovirus Is Effective in Oncolytic VirotherapyRobert A Berkeley, Lynette P Steele, Aat A Mulder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2008
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancerTimothy Kottke, Rosa M Diaz, Karen Kaluza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2014
The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical siteVanesa Alonso-Camino, Karishma Rajani, Timothy Kottke, et al.
Iscience|September 12, 2024
Cancer cell - Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinomaGiovanni Giangreco, Antonio Rullan, Yutaka Naito, et al.
BMC Cancer|September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocolDaniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Molecular Therapy Oncolytics|December 10, 2016
Immunogenicity of self tumor associated proteins is enhanced through protein truncationTim Kottke, Kevin G Shim, Vanesa Alonso-Camino, et al.
Research Square|November 28, 2024
Cancer Immunotherapy Using AIRE Conditioning of the Tumor EpitopeomeRichard Vile, Jose Pulido, Alex Chen, et al.
Molecular Therapy Oncolytics|May 27, 2017
Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and InvasionJulia V Cockle, Anke Brüning-Richardson, Karen J Scott, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Cancer Immunology Research|October 18, 2017
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor RecurrenceTim Kottke, Laura Evgin, Kevin G Shim, et al.
Frontiers in Oncology|January 18, 2024
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignanciesPablo Nenclares, Adrian Larkeryd, Floriana Manodoro, et al.
Cancer Immunology Research|September 14, 2018
Antibody-Neutralized Reovirus Is Effective in Oncolytic VirotherapyRobert A Berkeley, Lynette P Steele, Aat A Mulder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2008
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancerTimothy Kottke, Rosa M Diaz, Karen Kaluza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2014
The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical siteVanesa Alonso-Camino, Karishma Rajani, Timothy Kottke, et al.
Iscience|September 12, 2024
Cancer cell - Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinomaGiovanni Giangreco, Antonio Rullan, Yutaka Naito, et al.
BMC Cancer|September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocolDaniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Molecular Therapy Oncolytics|December 10, 2016
Immunogenicity of self tumor associated proteins is enhanced through protein truncationTim Kottke, Kevin G Shim, Vanesa Alonso-Camino, et al.
Research Square|November 28, 2024
Cancer Immunotherapy Using AIRE Conditioning of the Tumor EpitopeomeRichard Vile, Jose Pulido, Alex Chen, et al.
Molecular Therapy Oncolytics|May 27, 2017
Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and InvasionJulia V Cockle, Anke Brüning-Richardson, Karen J Scott, et al.
Pageof 14